Sino Biopharmaceutical Limited (SBMFF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Wan Chai, Hong Kong. El CEO actual es S. Y. Tse.
SBMFF tiene fecha de IPO 2010-02-22, 24,379 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $13.58B.
Sino Biopharmaceutical Limited is a Hong Kong-incorporated research and development pharmaceutical conglomerate operating in China since 2000. The company develops and commercializes a diverse portfolio of pharmaceuticals across multiple therapeutic areas, including oncology, cardio-cerebral vascular, hepatitis, orthopedic, and respiratory medicines, as well as innovative chemical pharmaceuticals and parenteral nutritional products. Beyond pharmaceutical manufacturing, Sino Biopharmaceutical operates an integrated healthcare ecosystem comprising hospital operations, optometry services, health food production, pharmaceutical distribution, and medical technology consulting. The company organizes its operations through three main segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others, generating revenue from drug sales, healthcare services, and strategic investments.
